Andreas Pascher

Suggest Changes
Learn More
BACKGROUND De novo sirolimus in calcineurin inhibitor-free regimens, although potentially useful to improve early renal function, are complicated by various drug-related side effects. METHODS We(More)
Gastroenteropancreatic neuroendocrine tumors and their metastases have an inconsistent appearance with only a small percentage of lesions appearing as cystic masses in computed tomography (CT) and(More)